Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Ifirmacombi

Ifirmacombi 150 mg/12.5 mg film-coated tablets Ifirmacombi 300 mg/12.5 mg film-coated tablets Ifirmacombi 300 mg/25 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 11

HOS-125175 · Präparat HOS-096013

Table 3: Adverse reactions reported with the use of hydrochlorothiazide alone Investigations Not known: electrolyte imbalance (including hypokalaemia and hyponatraemia, see section 4.4), hyperuricaemia, glycosuria, hyperglycaemia, increases in cholesterol and triglycerides Neoplasms benign, malignant Not known Non-melanoma skin cancer (Basal cell carcinoma and unspecified (incl cysts and and Squamous cell carcinoma)1 polyps) Cardiac disorders Not known: cardiac arrhythmias Blood and lymphatic system Not known: aplastic anaemia, bone marrow depression, disorders: neutropenia/agranulocytosis, haemolytic anaemia, leucopenia, thrombocytopenia Nervous system disorders Not known: vertigo, paraesthesia, light-headedness, restlessness Eye disorders Not known: transient blurred vision, xanthopsia, choroidal effusion, acute myopia and secondary acute angle- closure glaucoma Respiratory, thoracic and Very rare: acute respiratory distress syndrome (ARDS) (see mediastinal disorders section 4.4) Not known: respiratory distress (including pneumonitis and pulmonary oedema) Gastrointestinal disorders Not known: pancreatitis, anorexia, diarrhoea, constipation, gastric irritation, sialadenitis, loss of appetite

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.